Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats

Anesthesia and Analgesia

Volumn 116, Issue 2, 2013, Pages 482-490

  Chen, Yu Wen ^a   Hsieh, Pei Ling ^b   Chen, Yu Chung ^b   Hung, Ching Hsia ^c   Cheng, Juei Tang ^d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEAT SHOCK PROTEIN 72; INTERLEUKIN 6; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIABETIC NEUROPATHY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HYPERALGESIA; INSULIN DEPENDENT DIABETES MELLITUS; LATENT PERIOD; MALE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; STREPTOZOCIN DIABETES; TACTILE STIMULATION; TREADMILL EXERCISE; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; HOT TEMPERATURE; HSP72 HEAT-SHOCK PROTEINS; HYPERALGESIA; INTERLEUKIN-6; MALE; PERIPHERAL NERVES; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL STIMULATION; RATS; RATS, WISTAR; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 84872857816     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318274e4a0     Document Type: Article

References (68)

1. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-8
2. Calissi PT, Jaber LA. Peripheral diabetic neuropathy: current concepts in treatment. Ann Pharmacother 1995;29:769-77
3. Courteix C, Eschalier A, Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 1993;53:81-8
4. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-63
5. Zilliox L, Russell JW. Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol 2011;13:143-59
6. Yardley JE, Kenny GP, Perkins BA, Riddell MC, Malcolm J, Boulay P, Khandwala F, Sigal RJ. Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care 2012;35:669-75
7. Zisser H, Gong P, Kelley CM, Seidman JS, Riddell MC. Exercise and diabetes. Int J Clin Pract Suppl 2011;71-5
8. Shankarappa SA, Piedras-Rentería ES, Stubbs EB Jr. Forcedexercise delays neuropathic pain in experimental diabetes: effects on voltage-activated calcium channels. J Neurochem 2011;118:224-36
9. Otterman NM, van Schie CH, van der Schaaf M, van Bon AC, Busch-Westbroek TE, Nollet F. An exercise programme for patients with diabetic complications: a study on feasibility and preliminary effectiveness. Diabet Med 2011;28:212-7
10. Belotto MF, Magdalon J, Rodrigues HG, Vinolo MA, Curi R, Pithon-Curi TC, Hatanaka E. Moderate exercise improves leucocyte function and decreases inflammation in diabetes. Clin Exp Immunol 2010;162:237-43
11. Selagzi H, Buyukakilli B, Cimen B, Yilmaz N, Erdogan S. Protective and therapeutic effects of swimming exercise training on diabetic peripheral neuropathy of streptozotocininduced diabetic rats. J Endocrinol Invest 2008;31:971-8
12. Hung CH, Chen YW, Shao DZ, Chang CN, Tsai YY, Cheng JT. Exercise pretraining attenuates endotoxin-induced hemodynamic alteration in type I diabetic rats. Appl Physiol Nutr Metab 2008;33:976-83
13. Chen YW, Li YT, Chen YC, Li ZY, Hung CH. Exercise training attenuates neuropathic pain and cytokine expression after chronic constriction injury of rat sciatic nerve. Anesth Analg 2012;114:1330-7
14. Rossi DM, Valenti VE, Navega MT. Exercise training attenuates acute hyperalgesia in streptozotocin-induced diabetic female rats. Clinics (Sao Paulo) 2011;66:1615-9
15. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
16. Lynch J, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R, Salonen JT. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 1996;156:1307-14
17. Chen YW, Chen SH, Chou W, Lo YM, Hung CH, Lin MT. Exercise pretraining protects against cerebral ischaemia induced by heat stroke in rats. Br J Sports Med 2007;41: 597-602
18. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 2006;109:210-26
19. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005;115:71-83
20. Schäfers M, Sorkin LS, Sommer C. Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 2003;104:579-88
21. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain 2000;85:145-51
22. Zelenka M, Schäfers M, Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 2005;116:257-63
23. Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 1994;657:133-40
24. Schäfers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Rev Neurother 2007;7:1613-27
25. Hao S, Mata M, Glorioso JC, Fink DJ. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain 2006;2:6
26. Milligan ED, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005;21:2136-48
27. Sommer C. Animal studies on neuropathic pain: the role of cytokines and cytokine receptors in pathogenesis and therapy [in German]. Schmerz 1999;13:315-23
28. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10
29. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88
30. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve Growth Factor Study Group. Diabetes Care 2000;23:510-7
31. Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004;47:718-24
32. Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 1996;68:293-9
33. Hoybergs YM, Meert TF. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett 2007;417:149-54
34. Khan GM, Chen SR, Pan HL. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 2002;114:291-9
35. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122:561-8
36. Estacio RO, Regensteiner JG, Wolfel EE, Jeffers B, Dickenson M, Schrier RW. The association between diabetic complications and exercise capacity in NIDDM patients. Diabetes Care 1998;21:291-5
37. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006;20:216-23
38. Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ. The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002;96:119-27
39. Thorén P, Floras JS, Hoffmann P, Seals DR. Endorphins and exercise: physiological mechanisms and clinical implications. Med Sci Sports Exerc 1990;22:417-28
40. Rahkila P, Hakala E, Alén M, Salminen K, Laatikainen T. Betaendorphin and corticotropin release is dependent on a threshold intensity of running exercise in male endurance athletes. Life Sci 1988;43:551-8
41. Koltyn KF. Analgesia following exercise: a review. Sports Med 2000;29:85-98
42. Lee JH, McCarty R. Pain threshold in diabetic rats: effects of good versus poor diabetic control. Pain 1992;50:231-6
43. Lee JH, Cox DJ, Mook DG, McCarty RC. Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain 1990;40:105-7
44. Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy: effect of glucose on pain perception in humans. Am J Med 1984;77:79-82
45. Howarth FC, Marzouqi FM, Al Saeedi AM, Hameed RS, Adeghate E. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat. JOP 2009;10:485-91
46. Hung CH, Chang NC, Cheng BC, Lin MT. Progressive exercise preconditioning protects against circulatory shock during experimental heatstroke. Shock 2005;23:426-33
47. Noble EG, Milne KJ, Melling CW. Heat shock proteins and exercise: a primer. Appl Physiol Nutr Metab 2008;33:1050-65
48. Hu S, Ying Z, Gomez-Pinilla F, Frautschy SA. Exercise can increase small heat shock proteins (sHSP) and pre-and post-synaptic proteins in the hippocampus. Brain Res 2009;1249:191-201
49. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996;381:571-9
50. Hightower LE. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 1991;66:191-7
51. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205:2409-17
52. Yamagishi S, Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 2005;11:2279-99
53. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20
54. Bishnoi M, Bosgraaf CA, Abooj M, Zhong L, Premkumar LS. Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators. Mol Pain 2011;7:52
55. Yamakawa I, Kojima H, Terashima T, Katagi M, Oi J, Urabe H, Sanada M, Kawai H, Chan L, Yasuda H, Maegawa H, Kimura H. Inactivation of TNF-? ameliorates diabetic neuropathy in mice. Am J Physiol Endocrinol Metab 2011;301:E844-52
56. Boucher J, Castan-Laurell I, Daviaud D, Guigné C, Buléon M, Carpéné C, Saulnier-Blache JS, Valet P. Adipokine expression profile in adipocytes of different mouse models of obesity. Horm Metab Res 2005;37:761-7
57. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006; 55:774-9
58. Gordin D, Forsblom C, Rönnback M, Parkkonen M, Wadén J, Hietala K, Groop PH. Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes. Ann Med 2008;40:627-33
59. Muniandy S, Qvist R, Yan GO, Bee CJ, Chu YK, Rayappan AV. The oxidative stress of hyperglycemia and the inflammatory process in endothelial cells. J Med Invest 2009;56:6-10
60. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-86
61. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53
62. Cooper DM, Nemet D, Galassetti P. Exercise, stress, and inflammation in the growing child: from the bench to the playground. Curr Opin Pediatr 2004;16:286-92
63. Robertson K, Adolfsson P, Riddell MC, Scheiner G, Hanas R. Exercise in children and adolescents with diabetes. Pediatr Diabetes 2008;9:65-77
64. Jenni S, Wueest S, Konrad D, Stettler C. Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2010;89:e27-9
65. Park KM, Bowers WJ. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal 2010;22:977-83
66. Galassetti PR, Iwanaga K, Crisostomo M, Zaldivar FP, Larson J, Pescatello A. Inflammatory cytokine, growth factor and counterregulatory responses to exercise in children with type 1 diabetes and healthy controls. Pediatr Diabetes 2006;7:16-24
67. Nemet D, Oh Y, Kim HS, Hill M, Cooper DM. Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 2002;110:681-9
68. Pedersen BK, Akerström TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol 2007;103:1093-8